Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1673-1682

  Lee, Julie ^a   Dahl, Morten ^a   Nordestgaard, Børge G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; ESTROGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS CANCER; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROSOME; MOUTH CANCER; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; STOMACH CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

AGED; COCARCINOGENESIS; DENMARK; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; SMOKING;

EID: 79961232925     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1165     Document Type: Article

References (38)

1. World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
2. Kang DH. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 2002;13:540-9.
3. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol 2008;230:247-51.
4. Lacko M, Oude Ophuis MB, Peters WH, Manni JJ. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Anticancer Res 2009;29:753-61.
5. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 1998;58:5291-3. (Pubitemid 28551101)
6. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994;3:421-8. (Pubitemid 24083901)
7. Andrew AS, Gui J, Sanderson AC, Mason RA, Morlock EV, Schned AR, et al. Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet 2009;125:527-39.
8. da Silva Silveira V, Canalle R, Scrideli CA, Queiroz RG, Bettiol H, Valera ET, et al. Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009;33:898-901.
9. Figueroa JD, Malats N, Garcia-Closas M, Real FX, Silverman D, Kogevinas M, et al. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis 2008;29:1955-62.
10. Graziano C, Comin CE, Crisci C, Novelli L, Politi L, Messerini L, et al. Functional polymorphisms of the microsomal epoxide hydrolase gene: a reappraisal on a early-onset lung cancer patients series. Lung Cancer 2009;63:187-93.
11. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk [review]. Int J Oncol 2008;32:945-73.
12. Ihsan R, Chattopadhyay I, Phukan R, Mishra AK, Purkayastha J, Sharma J, et al. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India. J Gastroenterol Hepatol 2010;25:1456-62.
13. Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, et al. Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 2008;108:137-49. (Pubitemid 351623246)
14. Khedhaier A, Hassen E, Bouaouina N, Gabbouj S, Ahmed SB, Chouchane L. Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 2008;8:109.
15. Kiss I, Orsos Z, Gombos K, Bogner B, Csejtei A, Tibold A, et al. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 2007;27:2931-7. (Pubitemid 47228023)
16. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk, Collaborators (20) Abbas S, Baisch C, Braendle W, Brauch H, Kropp S, Parthimos M, et al. Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1--34-T>C polymorphism. Breast Cancer Res Treat 2010;120:737-44.
17. Northwood EL, Elliott F, Forman D, Barrett JH, Wilkie MJ, Carey FA, et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics 2010;20:315-26.
18. Ockenga J, Strunck S, Post C, Schulz HU, Halangk J, Pfutzer RH, et al. The role of epoxide hydrolase Y113H gene variant in pancreatic diseases. Pancreas 2009;38:e97-101.
19. Rosenberger A, Illig T, Korb K, Klopp N, Zietemann V, Wolke G, et al. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC Cancer 2008;8:60.
20. Rotunno M, Yu K, Lubin JH, Consonni D, Pesatori AC, Goldstein AM, et al. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One 2009;4:e5652.
21. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, et al. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 2009;125:837-43.
22. Skjelbred CF, Saebo M, Hjartaker A, Grotmol T, Hansteen IL, Tveit KM, et al. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer 2007;7:228.
23. Soucek P, Susova S, Mohelnikova-Duchonova B, Gromadzinska J, Moraviec-Sztandera A, Vodicka P, et al. Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe. Neoplasma 2010;57:415-21.
24. Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, et al. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:769-74. (Pubitemid 46650580)
25. Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, et al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer 2010;127:1547-61.
26. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 2008;29:1164-9. (Pubitemid 351958695)
27. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008;178:906-12.
28. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308. (Pubitemid 47080484)
29. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J 2002;23:620-6. (Pubitemid 35204246)
30. Lee J, Nordestgaard BG, Dahl M. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis. Eur Respir J 2011;37:18-25.
31. Yang X, Liang SH, Weyant DM, Lazarus P, Gallagher CJ, Omiecinski CJ. The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. J Pharmacol Exp Ther 2009;330:23-30.
32. Keicho N, Emi M, Kajita M, Matsushita I, Nakata K, Azuma A, et al. Overestimated frequency of a possible emphysema-susceptibility allele when microsomal epoxide hydrolase is genotyped by the conventional polymerase chain reaction-based method. J Hum Genet 2001;46:96-8. (Pubitemid 32231261)
33. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988;17:44-9.
34. Storm HH. The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ 1991:220-36.
35. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use.DanMed Bull 1997;44:535-9.
36. U.S. Department of Health and Human Services. The Health Consequences of Smoking: what it means to you. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
37. Chappell S, Daly L, Morgan K, Guetta-Baranes T, Roca J, Rabinovich R, et al. Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J 2008;32:931-7.
38. Siedlinski M, Postma DS, Smit HA, Boezen HM. No effects of EPHX1 polymorphisms on the level or change of FEV1 in the general population. Eur Respir J 2009;33:446-9.